UPDATE on angiotensin II receptor blocker (ARB) recalls – FDA alerts patients and health care professionals to Teva’s recall and Legacy’s expanded recall of losartan medication due to NMBA: https://go.usa.gov/xm9MR.

The agency also updated the list of recalled losartan products. To view the list, please visit: https://go.usa.gov/xm9MU.




Source